Adams JM, Brown WJ, Cremer NE, Eberle ED, Fewster ME, Lennette EH. Atypical demyelinating disease. Journal of Neurology, Neurosurgery and Psychiatry 1974;37:874-878.

Adams JM, Brown WJ, Eberle ED, Verity A. Vaccinia virus implicated in diffuse demyelinating disease. Proceedings of the Society for Experimental Biology and Medicine 1973; 143:799-803.

Adams JM, Francke E, Lillestol M. Poliomyelitis vaccination (letter). New England Journal of Medicine 1977;297:1290-1291.

Adams WG, Deaver KA, Cochi SL et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. Journal of the American Medical Association 1993;269:221-226.

Adenyi-Jones SC, Faden H, Ferdon MB, Kwong MS, Ogra PL. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants. Journal of Pediatrics 1992;120:686-689.

Adler JB, Mazzotta SA, Barkin JS. Pancreatitis caused by measles, mumps, and rubella vaccine. Pancreas 1991;6:489-490.

Adler SP. The effects and side effects of vaccines. Virginia Medical Journal 1982;109:410-411.

Advisory Commission on Childhood Vaccines, Martin Smith, Chairman. Vaccine Injury Compensation Program: past, present, and future. June 20, 1991. Unpublished.

Afzal MA, Pickford AR, Forsey T, Minor PD. Heterogeneous mumps vaccine. Lancet 1992;340:980-981.

Agrawal K, Pandit K, Kannan AT. Single dose tetanus toxoid: a review of trials in India with special reference to control of tetanus neonatorum. Indian Journal of Pediatrics 1984;81:285-295.

Aho K, Somer T, Salo OP. Rheumatoid factor and immuno-conglutinin responses following various vaccinations. Proceedings of the Society for Experimental Biology and Medicine 1967;124:229-33.

Ahonkhai VI, Lukacs LJ, Jonas LC, Calandra GB. Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide—Neisseria meningitidis outer membrane protein. Vaccine 1991;9(Suppl.):S38-41, S42-43.

Ahonkhai VI, Lukacs LJ, Jonas LC, Matthews H, Vella PP, Ellis RW et. al. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation. Pediatrics 1990;85(4 Pt 2):676-681.

Ahronheim G, Allard M, Forsey T, Rydbeck R, Teuwen D, Yamada A. Mumps associated with trivalent vaccine containing Urabe Am 9 mumps strain (abstract). Program Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, p. 148. Washington, DC: American Society for Microbiology; 1990.

Ahronheim GA, Allard M, Forsey T, Rydbeck R, Teuwen DE, Yamada A. Mumps associated with trivalent vaccine containing Urabe Am 9 mumps strain (abstract). Pediatric Research 1991;29:166A.

Ajjan N, Bentejac MC. [Anti-mumps vaccination] La vaccination anti-ourlienne. Revue de Pediatric 1985;21:55-61.

Ajjan N, Biron G, Bentejac MC. [The dangers of vaccination] Les dangers de la vaccination. Revue Medicale 1980;21:739-750.

Ajjan N, Fayet MT, Biron G et. al. Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine. Developments in Biological Standardization 1978;41:209-216.

Akama K, Yamamoto A. [Side effects of tetanus toxoid. II. Antigenic materials derived from the constituents of the medium for toxoid preparation]. Nippon Saikingaku Zasshi 1969;24:595-601.

Akosa AB, All MH, Khoo CT, Evans DM. Angiolymphoid hyperplasia with eosinophilia associated with tetanus toxoid vaccination. Histopathology 1990;16:589-593.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement